Tags

Type your tag names separated by a space and hit enter

[Mobile apps and their usage in rheumatology].
Z Rheumatol. 2020 Aug; 79(6):554-561.ZR

Abstract

The increasing use of smartphones is accompanied by a significant increase in the use of mobile applications (apps). Chronically ill patients could permanently profit from this development.This development is fuelled by the Digital Healthcare Act (DVG), whereby patients have a legal claim to certain apps, so-called digital health applications (DiGAs), which are reimbursed by the statutory health insurance companies. Especially in the field of rheumatology, there are various opportunities to implement apps in the management of chronic diseases and their comorbidities. Furthermore, rheumatic patients and rheumatologists are becoming interested in apps and are willing to use them in the daily routine. This article tries to shed light on the chances and risks of apps and gives a first insight into the digital landscape of rheumatology apps in Germany.

Authors+Show Affiliations

Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin, Charitéplatz 1, 10117, Berlin, Deutschland. martin.krusche@charite.de.Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20253, Hamburg, Deutschland.ABATON GmbH, Berlin, Reinhardtstr. 17, 10117, Berlin, Deutschland.Medizinische Klinik 3 - Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Ulmenweg 18, 91054, Erlangen, Deutschland. johannes.knitza@uk-erlangen.de.

Pub Type(s)

Journal Article

Language

ger

PubMed ID

32472178

Citation

Krusche, M, et al. "[Mobile Apps and Their Usage in Rheumatology]." Zeitschrift Fur Rheumatologie, vol. 79, no. 6, 2020, pp. 554-561.
Krusche M, Ruffer N, Grahammer M, et al. [Mobile apps and their usage in rheumatology]. Z Rheumatol. 2020;79(6):554-561.
Krusche, M., Ruffer, N., Grahammer, M., & Knitza, J. (2020). [Mobile apps and their usage in rheumatology]. Zeitschrift Fur Rheumatologie, 79(6), 554-561. https://doi.org/10.1007/s00393-020-00822-2
Krusche M, et al. [Mobile Apps and Their Usage in Rheumatology]. Z Rheumatol. 2020;79(6):554-561. PubMed PMID: 32472178.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Mobile apps and their usage in rheumatology]. AU - Krusche,M, AU - Ruffer,N, AU - Grahammer,M, AU - Knitza,J, PY - 2020/5/31/pubmed PY - 2020/9/12/medline PY - 2020/5/31/entrez KW - Digital health KW - Mobile applications KW - Rheumatology KW - eHealth KW - mHealth SP - 554 EP - 561 JF - Zeitschrift fur Rheumatologie JO - Z Rheumatol VL - 79 IS - 6 N2 - The increasing use of smartphones is accompanied by a significant increase in the use of mobile applications (apps). Chronically ill patients could permanently profit from this development.This development is fuelled by the Digital Healthcare Act (DVG), whereby patients have a legal claim to certain apps, so-called digital health applications (DiGAs), which are reimbursed by the statutory health insurance companies. Especially in the field of rheumatology, there are various opportunities to implement apps in the management of chronic diseases and their comorbidities. Furthermore, rheumatic patients and rheumatologists are becoming interested in apps and are willing to use them in the daily routine. This article tries to shed light on the chances and risks of apps and gives a first insight into the digital landscape of rheumatology apps in Germany. SN - 1435-1250 UR - https://news.unboundmedicine.com/medline/citation/32472178/[Mobile_apps_and_their_usage_in_rheumatology]. L2 - https://dx.doi.org/10.1007/s00393-020-00822-2 DB - PRIME DP - Unbound Medicine ER -